Dersleri yüzünden oldukça stresli bir ruh haline sikiş hikayeleri bürünüp özel matematik dersinden önce rahatlayabilmek için amatör pornolar kendisini yatak odasına kapatan genç adam telefonundan porno resimleri açtığı porno filmini keyifle seyir ederek yatağını mobil porno okşar ruh dinlendirici olduğunu iddia ettikleri özel sex resim bir masaj salonunda çalışan genç masör hem sağlık hem de huzur sikiş için gelip masaj yaptıracak olan kadını gördüğünde porn nutku tutulur tüm gün boyu seksi lezbiyenleri sikiş dikizleyerek onları en savunmasız anlarında fotoğraflayan azılı erkek lavaboya geçerek fotoğraflara bakıp koca yarağını keyifle okşamaya başlar
Reach Us +44-3308187254


Editor - Irfan A Mohammed | ALEXION PHARMACEUTICALS | 26934

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Irfan A Mohammed

Irfan A Mohammed
Irfan A Mohammed Associate Director, Operations Asset Leader, Alexion Pharmaceuticals, New Haven, United States


Irfan A. Mohammed is a CMC Development Scientist/ Leader with comprehensive experience in ideating, designing, developing, and scaling innovative and complex drug development programs ranging from oral solids to sterile dosage forms (Injectables and Ophthalmics) from pre-clinical stage to commercialization. Irfan A. Mohammed has led the development of drug products in various disease spaces, such as, oncology, hematology, neurology, ophthalmology, hospital, and critical care medicine, including rare diseases. He is an inventor/ co-inventor on 30+ patents awarded/ pending in the US and rest of the world (ROW).

Currently serving as an  Associate Director, CMC Development Leader at Alexion Pharmaceuticals, his work focuses on leading global Chemistry, Manufacturing and Controls (CMC) development teams, such as, drug substance, drug product , analytical sciences, device, clinical manufacturing, clinical supply chain, regulatory CMC and quality management teams to advance innovative therapies for rare diseases from R&D to clinics. His experience includes leading drug product design and development (pre-formulation and formulation), manufacturing science and technology (MS&T), such as, manufacturing process development, characterization, verification, validation, and formulation/fill/finish operations), regulatory CMC and compliance. His research experience encompasses both academia and industry focused on developing robust drug product formulation and process strategies for new molecular entities and already approved drug substances, primarily within sterile dosage forms, such as, injectables and ophthalmic drug products, including aqueous, non-aqueous, lyophilized, suspensions, emulsions formulations, pre-filled syringes/ combination products, blow fill seal (BFS) and infusion bags. His work aims to develop drug products to improve the overall quality of life in patients, adding value to the patients, healthcare providers and the healthcare system.  

Irfan is passionate to contribute and add value to the overall healthcare ecosystem, beginning from drug development to healthcare delivery and health outcomes leveraging new and innovative approaches, such as, digital applications in drug development and healthcare.

Irfan A. Mohammed is also currently pursuing his Doctorate Degree in Pharmaceutics from Philadelphia College of Pharmacy, University of Sciences, where his research work focuses on developing long acting injectables drug delivery systems. He obtained his Master’s degree in Pharmaceutics and Industrial Pharmacy from Long Island University, Brooklyn, NY, where his research work focused on development, characterization and understanding the process variables in the preparation of stable polymeric nanoparticles using wet media milling to improve the drug delivery of an antifungal agent through topical/transdermal and oral solid dosage forms utilizing and comparing regular form of drug, nanoparticles and solid dispersion technologies. He graduated with a Bachelor’s degree in Pharmacy from Jawaharlal Nehru Technological University, Hyderabad, India

Research Interest

Pharmaceutics, Chemistry, Manufacturing and Controls, Advance Medicine, Analytical Sciences